Ravelcare, the digital beauty disruptor specializing in customized hair and skincare, closed its IPO on a high note with 438x overall subscription (retail at 463x!). As of Dec 5, 2025, Ravelcare IPO GMP holds at ₹80, pointing to a ₹210 estimated listing – 62% premium over ₹130 band. Allotment out today, listing Dec 8 on BSE SME. What Fueled the Subscription Fire? Retail rush: 463x bid, thanks to Gen Z’s love for personalized BPC products. GMP surge: From ₹16 (Nov 26) to ₹80 – reflects post-close optimism. Fundraise: Full fresh issue of ₹24.10 Cr for scaling e-com and outlets. Market fit: 27% EBITDA margins in competitive beauty space. Key Metrics Table Issue Price (Upper Band) ₹130 Current GMP ₹80 Estimated Listing Price ₹210 Potential Gain 62% Investment Play? Strong buy for beauty sector bulls (India’s $20B market by 2025). Risks: Competition from Nykaa. Aim for 50%+ listing flip. Verdict: A subscriber’s dream – Dec 8 could sparkle! Ravelcare IPO GMP, Ravelcare IPO subscription 438x, Ravelcare beauty IPO review, Ravelcare listing Dec 8, Ravelcare IPO expected gain Post navigation Exato Technologies IPO GMP Explodes to 126%: AI Tech Listing Today – Multibagger Alert? Luxury Time IPO GMP Hits 91% on Day 2: Retail Surge in Watch Retail – SME Gem for Dec 11?